Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Parkin ELISA Kit (AC3583)
Cat.#: ASET-2172
Specifications
Description Human Parkin ELISA Kit allows for the in vitro quantitative determination of human Parkin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1888 Human CLN3 ELISA Kit (AC3299) Quantitative inquiry ASET-1007 Human MT3 ELISA Kit (AC2418) Quantitative inquiry ASET-1377 Rat Adiponectin ELISA Kit (AC2788) Quantitative inquiry ASET-1030 Human Dynamin 1 ELISA Kit (AC2441) Quantitative inquiry ASET-1247 Human GSK3 beta ELISA Kit (AC2658) Quantitative inquiry ASET-1042 Human Pannexin 1 ELISA Kit (AC2453) Quantitative inquiry ASET-2187 Mouse Syndecan 4 ELISA Kit (AC3598) Quantitative inquiry ASET-1144 Human Neuroglobin ELISA Kit (AC2555) Quantitative inquiry ASET-1280 Human Artemin ELISA Kit (AC2691) Quantitative inquiry ASET-1850 Human Oxytocin-neurophysin 1 ELISA Kit (AC3261) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket